M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.52 EUR -3.34% Market Closed
Market Cap: 104.5m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maat Pharma SA
Capital Expenditures Peer Comparison

Comparables:
VLA
G
GNFT
IVA
ALERS
OSE

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Capital Expenditures
-€1.1m
CAGR 3-Years
-51%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Capital Expenditures
-€11.3m
CAGR 3-Years
42%
CAGR 5-Years
-13%
CAGR 10-Years
-8%
G
Genfit SA
PAR:GNFT
Capital Expenditures
-€1.2m
CAGR 3-Years
-111%
CAGR 5-Years
10%
CAGR 10-Years
-13%
Inventiva SA
PAR:IVA
Capital Expenditures
-€540k
CAGR 3-Years
-6%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Eurobio Scientific SA
PAR:ALERS
Capital Expenditures
-€4.1m
CAGR 3-Years
-13%
CAGR 5-Years
-18%
CAGR 10-Years
-17%
OSE Immunotherapeutics SA
PAR:OSE
Capital Expenditures
-€250k
CAGR 3-Years
-4%
CAGR 5-Years
7%
CAGR 10-Years
N/A

See Also

What is Maat Pharma SA's Capital Expenditures?
Capital Expenditures
-1.1m EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Capital Expenditures amounts to -1.1m EUR.

What is Maat Pharma SA's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-30%

Over the last year, the Capital Expenditures growth was -65%. The average annual Capital Expenditures growth rates for Maat Pharma SA have been -51% over the past three years , -30% over the past five years .

Back to Top